Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Explore innovative nutritional and microbial strategies for effectively treating acne, alopecia, and atopic dermatitis.

Opens in a new tab or window Higher-potency topical corticosteroids, JAK inhibitors, and tacrolimus 0.1% were deemed the most effective topical anti-inflammatory treatments for atopic dermatitis ...

Long-term treatment of adolescents with moderate-to-severe atopic dermatitis with upadacitinib is safe and effective through 76 weeks.

Treatment with the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) showed a favorable long-term benefit-risk profile ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

Researchers recently identified five extrapulmonary treatable traits in asthma that are clinically relevant and have a clear ...

Individuals who suffer from atopic dermatitis are three times more likely to develop anxiety, depression and sleep ...

Leerink Partners analyst David Risinger has maintained their bullish stance on LLY stock, giving a Buy rating today. David Risinger’s ...

Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in JAMA ...